The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...
Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...
On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...
Avadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking label expansion of Lumryz. The drug is now approved in the United States ...
The U.S. FDA’s new draft guidance for the voluntary incorporation of patient preference information (PPI) in device development says that PPI would be included in product labels for cleared or ...
Information about nitrosamine impurities in medications. National Library of Medicine: DailyMed. Cymbalta—duloxetine hydrochloride capsule, delayed release [drug label].
There have been signs that the FDA is considering regulatory action, too. In 2023, the agency issued a request for information on food labeling in online grocery shopping, citing previous research ...
Suppositories are solid medications that are inserted into the body. Different types of suppositories can be inserted into the rectum, vagina, or urethra (the tube where urine leaves your body).